2m 2m 2m 2m 2m 2m 2m
VTV THERAP-A (VTVT)
NASDAQ
$33.34+$0.09 (+0.26%)
Price as of Aug 21, 2026 7:30 PM EDT- $131.5MMarket Cap
- 107.84%1-Year Change
- BiotechnologyIndustry
VTV THERAP-A (VTVT)
$33.34+$0.09 (+0.26%)
VTVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $33.26 | ||
Change | +$0.18 (+0.53%) | ||
Open | $33.19 | ||
High | $33.85 | ||
Low | $32.78 | ||
Previous Close | $33.08 | ||
Volume | 26,674 | ||
30-Day Average Volume | 97,803 | ||
1-Week Change | 10.41% | ||
1-Month Change | 1.05% | ||
1-Year Change | 107.84% | ||
3-Year Change | 22.26% | ||
5-Year Change | -51.38% | ||
Fundamentals | |||
Shares Outstanding | 4.0M | ||
Total Assets | $87.6M | ||
Market Cap | $131.5M | ||
Enterprise Value | $44.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$13.1M | ||
Free Cash Flow | -$11.4M | ||
EBIT | -$13.1M | ||
EBITDA | -$13.1M | ||
Net Working Capital | $80.6M | ||
EPS | -$1.05 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -32 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 11/21/2023 | ||
Earnings & Revenue